Kropf, Heinz; Nuernberg, Wolfgang, Journal of Chemical Research, Miniprint, 1991, p. 1532 - 1565
作者:Kropf, Heinz、Nuernberg, Wolfgang
DOI:——
日期:——
KROPF, H.;VON, WALLIS, H., LIEBIGS ANN. CHEM., 1983, N 4, 610-623
作者:KROPF, H.、VON, WALLIS, H.
DOI:——
日期:——
ORAL IODINE DOSAGE FORM
申请人:BioPharmX, Inc.
公开号:US20170304359A1
公开(公告)日:2017-10-26
Provided is an oral dosage form comprising a deliverable form of iodine for treating symptoms related to fibrocystic breast condition, for prophylactically maintaining breast health, for treating fibrocystic breasts or breast cancer in pre-menopausal women, for prophylactically maintaining prostate health, and for treating benign prostate hyperplasia along with related methods for making and administering such dosage form. More particularly, this disclosure relates to an oral dosage form that is effective to deliver supraphysiologic levels of molecular iodine. The oral dosage form generally comprises a source of iodine and a reactive agent, wherein the source of iodine and/or the reactive agent are provided in excess.
Kropf,H.; Bernert,C.-R., Justus Liebigs Annalen der Chemie, 1971, vol. 751, p. 109 - 120
作者:Kropf,H.、Bernert,C.-R.
DOI:——
日期:——
Kropf, Heinz; Wallis, Helmut von, Liebigs Annalen der Chemie, 1983, # 4, p. 610 - 623